794. Infectivity of smear positive pulmonary TB after two weeks of rifampicin based anti tuberculous therapy
Session: Poster Abstract Session: Tuberculosis and Other Mycobacterial Infections
Thursday, October 4, 2018
Room: S Poster Hall
  • TB-Dr. Nada -last update new.pdf (4.0 MB)
  • Background: Pulmonary tuberculosis (TB) remains one of the leading infectious causes of morbidity and mortality worldwide. Most data showed that infectiousness of pulmonary TB diminishes rapidly after 2 weeks of effective anti-tuberculous therapy and the bacilli seen in the smear after 2 weeks are most likely non-viable. We aim to assess this hypothesis by doing sputum culture after 2 weeks of therapy to assess the viability of the bacilli in the smear .

    Methods: A prospective cohort study was conducted on patients admitted to Communicable Disease Centre (CDC), Qatar with smear positive pulmonary tuberculosis during the period November 2013— November 2014.  We repeated sputum smear and culture after 2 weeks of rifampicin based regimen to assess the infectivity. Demographic and clinical characteristics of patients was evaluated and compared to smear and culture conversion rate.


    Ninety five cases were included in the study. All had sputum smear and culture after 2 weeks of supervised rifampicin based therapy (Table 1). Sputum culture at two weeks of treatment was positive in 91 cases (95.7%) and only 4 cases were culture negative after two weeks.  Demographic and clinical characteristics were compared to the culture status after 2 weeks, found Patient from Indian subcontinent and symptoms duration more than one  month are less likely to clear infection after 2 weeks   with P value 0.01 and 0.009 respectively  (table 2).

    The calculated mean for sputum smear and culture conversion rate was 4 and 8 weeks respectively. The presence of cough and the duration of symptoms were associated significantly with rapid sputum conversion (p value <0.05), however presence of cavity on CXR had no statistical significant effect (table 3).

    Conclusion: Majority of our patients in the study have positive TB culture after two weeks of rifampicin based anti-tuberculosis therapy. So discontinuation of the isolation after 2 weeks of treatment assuming that bacilli in the smear are non-viable may not be safe.


    Faraj Alhowady, MD1, Nada Elmaki, MD, MRCP1, Maisa Ali, MD, MRCP2, Ahmad Husain, MD1, Muna Al-Maslamani, MBBS, CABMS , MSc HCM -RCSI3, Zubaida Alsuwaidi, Senior Clinical Scientist4, Mahmoud Mohamed, MSc5 and Hussam Alsoub, Senior Consultant6, (1)Medicine, Hamad medical corporation, doha, Qatar, (2)Medicine, hamad medical corporation, doha, Qatar, (3)Internal Medicine, Infectious Diseases, Weill Cornell Medical College-Qatar &Communicable Disease Center,Hamad medical corporation, doha, Qatar, (4)TB Labratory, Hamad medical corporation, doha, Qatar, (5)Pharmacy, Hamad Medical Corporation, Doha, Qatar, (6)Infectious Disease, Hamad Medical Corporation, Doha, Qatar


    F. Alhowady, None

    N. Elmaki, None

    M. Ali, None

    A. Husain, None

    M. Al-Maslamani, None

    Z. Alsuwaidi, None

    M. Mohamed, None

    H. Alsoub, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.